AMANDA LUCKE: Open Payments
NPI 1003083684 · FISHERS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,591 in 124 payments from 26 companies in 2025. Trend: 2023 $2,492 · 2024 $1,701 · 2025 $4,591
Food & beverage: $2,457Consulting: $2,100Education: $34
| Company | Payments | Amount |
|---|---|---|
| Eli Lilly and Company | 2 | $2,100 |
| CSL Behring | 12 | $331 |
| AstraZeneca Pharmaceuticals LP | 9 | $303 |
| Novartis Pharmaceuticals Corporation | 10 | $190 |
| ARS Pharmaceuticals Operations, Inc. | 8 | $180 |
| GlaxoSmithKline, LLC. | 16 | $174 |
| Blueprint Medicines Corporation | 4 | $170 |
| Amgen Inc. | 9 | $164 |
| PFIZER INC. | 15 | $122 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $105 |
Products named: EBGLYSS, TEZSPIRE, AYVAKIT, Hizentra, NEFFY, AIRSUPRA, Xolair, NUCALA.
Industry payments across IN — which companies pay providers there.
